Works matching DE "PHARMACEUTICAL industry mergers"

Results: 132

So Tell Me Again, Why Are We Doing This?

Published in:

Bio-IT World, 2010, v. 9, n. 1, p. 12

By:

BUSH, ERNIE

Publication type:

Article

Making Up Is Hard to Do: Knowledge Acquisition Strategies and the Nature of New Product Innovation.

Published in:

Journal of Product Innovation Management, 2016, v. 33, n. 4, p. 472, doi. 10.1111/jpim.12298

By:

Dunlap, Denise;
McDonough, Edward F.;
Mudambi, Ram;
Swift, Tim

Publication type:

Article

In This Issue.

Published in:

Journal of Product Innovation Management, 2016, v. 33, n. 4, p. 380, doi. 10.1111/jpim.12324_1

By:

Barczak, Gloria

Publication type:

Article

Relaciones laborales en fusiones y adquisiciones transnacionales. Una aproximación política.

Published in:

Revista Española de Investigaciones Sociológicas, 2007, n. 120, p. 11, doi. 10.2307/40184832

By:

Ortiz, Luis;
Coller, Xavier;
Edwards, Tony;
Rees, Chris;
Wortmann, Michael

Publication type:

Article

The Impact of Off-Patent Drug Acquisitions on Prices.

Published in:

2018

By:

Gupta, Ravi;
Henkel, Alexis;
Forman, Howard P.;
Ross, Joseph S.

Publication type:

journal article

Big pharma's mega-mergers contribute to growth.

Published in:: Australian Journal of Pharmacy, 2010, v. 91, n. 1077, p. 52
Publication type:: Article

A shortage link?

Published in:

Nature Medicine, 2011, v. 17, n. 7, p. 761, doi. 10.1038/nm0711-761b

By:

Weaver, Janelle

Publication type:

Article

Drug Industry Mergers Won't Necessarily Benefit R&D.

Published in:

Research Technology Management, 2000, v. 43, n. 4, p. 10, doi. 10.1080/08956308.2000.11671362

By:

Henderson, Rebecca

Publication type:

Article

Anti-Inversion Rules, the Pfizer-Allergan Merger, and the U.S. Chamber of Commerce's Challenge.

Published in:

Review of Banking & Financial Law, 2016, v. 36, n. 1, p. 16

By:

Mello, Daniel

Publication type:

Article

A hotbed for vaccines.

Published in:

Chemistry & Industry, 2013, v. 77, n. 10, p. 46, doi. 10.1002/cind.7710_15.x

By:

Nair, A.

Publication type:

Article

Business digest.

Published in:: Chemistry & Industry, 2013, v. 77, n. 7, p. 19
Publication type:: Article

Business Digest.

Published in:: Chemistry & Industry, 2012, v. 76, n. 3, p. 15, doi. 10.1002/cind.7603_4.x
Publication type:: Article

Business digest.

Published in:: Chemistry & Industry, 2011, p. 14, doi. 10.1002/cind.7524_5.x
Publication type:: Article

Companies, technology & environment.

Published in:

Chemistry & Industry, 2011, n. 7, p. 13

By:

Whitfield, Mark

Publication type:

Article

Companies, technology & environment.

Published in:

Chemistry & Industry, 2011, n. 3, p. 13

By:

Eisberg, Neil

Publication type:

Article

Business digest.

Published in:

Chemistry & Industry, 2010, n. 14, p. 11

By:

Eisberg, Neil

Publication type:

Article

Pharma tackles pipelines.

Published in:

Chemistry & Industry, 2010, n. 6, p. 6

By:

Dorey, Emma

Publication type:

Article

Pfizer slashes R&D sites.

Published in:

Chemistry & Industry, 2009, n. 22, p. 6

By:

Dorey, Emma

Publication type:

Article

Companies, technology & environment.

Published in:

Chemistry & Industry, 2009, n. 20, p. 13

By:

Eisberg, Neil

Publication type:

Article

Genentech rejects Roche.

Published in:

Chemistry & Industry, 2008, n. 16, p. 5

By:

Dorey, Emma

Publication type:

Article

GSK looks to ageing to boost R&D.

Published in:

Chemistry & Industry, 2008, n. 12, p. 6

By:

Dorey, Emma

Publication type:

Article

Business Digest.

Published in:

Chemistry & Industry, 2007, n. 24, p. 13

By:

Eisberg, Neil

Publication type:

Article

SETTING THE “RIGHT” GOAL: POST M&A INNOVATION PERFORMANCE AND GOAL ORIENTATION.

Published in:

Business: Theory & Practice, 2020, v. 21, n. 2, p. 555, doi. 10.3846/btp.2020.12083

By:

DOAN, Trang Thu

Publication type:

Article

NOVARTIS CONSIDERS SELLING GENERIC DERMATOLOGY DRUGS BUSINESS.

Published in:: Journal of Clinical & Aesthetic Dermatology, 2017, v. 10, n. 10, p. 48
Publication type:: Article

Comparing Domestic and Cross-Border Mergers and Acquisitions in the Pharmaceutical Industry.

Published in:

Atlantic Economic Journal, 2015, v. 43, n. 4, p. 489, doi. 10.1007/s11293-015-9476-0

By:

Banerjee, Tannista;
Nayak, Arnab

Publication type:

Article

What to Know About CROs.

Published in:

Applied Clinical Trials, 2012, p. 16

By:

Olson, Kevin

Publication type:

Article

Enough Speculation, Time to Act.

Published in:

Applied Clinical Trials, 2011, v. 20, n. 3, p. 10

By:

Henderson, Lisa

Publication type:

Article

M&A in the Pharma Industry.

Published in:

Applied Clinical Trials, 2010, v. 19, n. 11, p. 36

By:

Pervaaz, Viq

Publication type:

Article

Agreements.

Published in:: Applied Clinical Trials, 2002, v. 11, n. 3, p. 87
Publication type:: Article

News update.

Published in:: Applied Clinical Trials, 2000, v. 9, n. 2, p. 12
Publication type:: Article

Big drug company created.

Published in:

Nature, 1989, v. 338, n. 6217, p. 610, doi. 10.1038/338610a0

By:

Ezzell, C.

Publication type:

Article

News in brief.

Published in:: Nature Reviews Drug Discovery, 2013, v. 12, n. 2, p. 91, doi. 10.1038/nrd3947
Publication type:: Article

Deal watch: Biogen acquires Stromedix to pursue novel fibrosis therapy.

Published in:

Nature Reviews Drug Discovery, 2012, v. 11, n. 4, p. 260, doi. 10.1038/nrd3708

By:

Crunkhorn, Sarah

Publication type:

Article

The impact of mergers on pharmaceutical R&D.

Published in:

2011

By:

LaMattina, John L.

Publication type:

journal article

Modifying protein misfolding.

Published in:

Nature Reviews Drug Discovery, 2010, v. 9, n. 11, p. 825, doi. 10.1038/nrd3316

By:

Jones, Dan

Publication type:

Article

Luciano Rossetti.

Published in:

2010

By:

Hughes, Bethan

Publication type:

Interview

Deal watch: M&A activity in 2009.

Published in:

Nature Reviews Drug Discovery, 2010, v. 9, n. 2, p. 95, doi. 10.1038/nrd3114

By:

Walker, Josef

Publication type:

Article

Creating a company.

Published in:: Nature Reviews Drug Discovery, 2007, v. 6, n. 1, p. 93, doi. 10.1038/nrd2218
Publication type:: Article

Pipeline problems are increasing the urge to merge.

Published in:

Nature Reviews Drug Discovery, 2006, v. 5, n. 12, p. 977, doi. 10.1038/nrd2206

By:

Frantz, Simon

Publication type:

Article

Aventis-Sanofi: a good R&D merger?

Published in:

Nature Reviews Drug Discovery, 2004, v. 3, n. 3, p. 193, doi. 10.1038/nrd1358

By:

Frantz, Simon

Publication type:

Article

Eli Lilly to buy Novartis' animal health unit for $5.4bn.

Published in:: Veterinary Ireland Journal, 2014, v. 4, n. 5, p. 238
Publication type:: Article

Glaxo SmithKline Merge Into World's Biggest Drug Firm.

Published in:

Ageing International, 1999, v. 25, n. 3, p. 4

By:

Hetherington, Janet L.

Publication type:

Article

IN NEED OF TREATMENT? MERGER CONTROL, PHARMACEUTICAL INNOVATION, AND CONSUMER WELFARE.

Published in:

Journal of Legal Medicine, 2000, v. 21, n. 3, p. 271, doi. 10.1080/01947640050174813

By:

Ben-Asher, Dror

Publication type:

Article

Predicting Competitive Effects from Prescription Drug Mergers: How Standard Economic Analysis Can Go Wrong.

Published in:

Antitrust Bulletin, 2014, v. 59, n. 3, p. 593, doi. 10.1177/0003603X1405900309

By:

Werden, Gregory J.

Publication type:

Article

FTC v. Lundbeck: Is Anything in Antitrust Obvious, Like, Ever?

Published in:

Antitrust Bulletin, 2014, v. 59, n. 3, p. 557, doi. 10.1177/0003603X1405900307

By:

Sagers, Chris;
Brunell, Richard M.

Publication type:

Article

A lesson from Japan: Research and development efficiency is a key element of pharmaceutical industry consolidation process.

Published in:

Drug Discoveries & Therapeutics, 2014, v. 8, n. 1, p. 57, doi. 10.5582/ddt.8.57

By:

Hirohisa Shimura;
Sachiko Masuda;
Hiromichi Kimura

Publication type:

Article

ROCHE TO ACQUIRE SPARK THERAPEUTICS.

Published in:: Applied Clinical Trials, 2019, v. 28, n. 3, p. 14
Publication type:: Article

TAKEDA AGREES TO $62 BILLION TAKEOVER OF SHIRE.

Published in:: Applied Clinical Trials, 2018, v. 27, n. 6, p. 13
Publication type:: Article

CRO: FEDERAL TAX SUPPORT KEEPS AUSTRALIA COMPETITIVE FOR CLINICAL TRIALS.

Published in:: Applied Clinical Trials, 2018, v. 27, n. 6, p. 12
Publication type:: Article

Giants wrestle over ImClone.

Published in:

Nature Biotechnology, 2008, v. 26, n. 12, p. 1323, doi. 10.1038/nbt1208-1323b

By:

Mack, George S

Publication type:

Article